Skip to main content
Top
Published in: Molecular Cancer 1/2014

Open Access 01-12-2014 | Research

Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model

Authors: Tobias Brodbeck, Nina Nehmann, Anja Bethge, Gero Wedemann, Udo Schumacher

Published in: Molecular Cancer | Issue 1/2014

Login to get access

Abstract

Background

For long, natural killer (NK) cells have been suspected to play a critical role in suppressing the development of spontaneous metastases in cancer patients. Despite a wide range of studies it remains unclear so far to what extent primary tumor growth together with formation of distant metastases and NK cell activity influence each other.

Methods

To precisely investigate the role of NK cells with a perforin-deficiency in cancer growth and metastasis formation, human HT29 colon cancer cells were subcutaneously grafted into pore forming protein and recombination activating gene 2 double knock out (pfp/rag2) mice and in recombination activating gene 2 only knock out (rag2) mice both with black six background. Both mice lack B and T cell functions due to the absence of rag2.

Results

Primary tumors developed in 16/16 in pfp/rag2 and 20/20 rag2 mice. At sacrifice primary tumor weight did not differ significantly. However, tumors grew faster in pfp/rag2 mice (50 days) than in pfp/rag2 mice (70 days). Circulating tumor cells (CTC) in murine blood were nearly three times higher in pfp/rag2 (68 cells/ml) than in rag2 mice (24 cells/ml). Lung metastases occurred frequently in pfp/rag2 mice (13/16) and infrequently in rag2 mice (5/20). The mean number of metastases was 789 in pfp/rag2 mice compared to 210 in rag2 mice. Lung metastases in pfp/rag2 mice consisted of 10–100 tumor cells while those in rag2 mice were generally disseminated tumor cells (DTCs).
Computer modelling showed that perforin-dependent killing of NK cells decelerates the growth of the primary tumour and kills 80% of CTCs. Furthermore, perforin-mediated cytotoxicity hampers the proliferation of the malignant cells in host tissue forcing them to stay dormant for at least 30 days.

Conclusion

The results exactly quantified the effect of perforin-dependent direct cytotoxicity of NK cells on HT29 on primary tumor growth, number of CTCs in the blood and the number of metastases. The largest effects were seen in the number of mice developing spontaneous lung metastases and the mean number of lung metastases. Hence, perforin-mediated cytotoxicity used for direct killing by NK cells is more important than indirect killing by secretion of death-inducing ligands by NK cells.
Appendix
Available only for authorised users
Literature
1.
go back to reference Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA: A Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D: Global cancer statistics. CA: A Cancer J Clin. 2011, 61: 69-90. 10.3322/caac.20107.
2.
go back to reference Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013CrossRefPubMed Hanahan D, Weinberg RA: Hallmarks of cancer: the next generation. Cell. 2011, 144: 646-674. 10.1016/j.cell.2011.02.013CrossRefPubMed
3.
go back to reference Watson AJM, Collins PD: Colon cancer: a civilization disorder. Dig Dis. 2011, 29: 222-228. 10.1159/000323926CrossRefPubMed Watson AJM, Collins PD: Colon cancer: a civilization disorder. Dig Dis. 2011, 29: 222-228. 10.1159/000323926CrossRefPubMed
5.
go back to reference Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol. 1997, 9: 24-34. 10.1016/S0952-7915(97)80155-0CrossRefPubMed Biron CA: Activation and function of natural killer cell responses during viral infections. Curr Opin Immunol. 1997, 9: 24-34. 10.1016/S0952-7915(97)80155-0CrossRefPubMed
6.
go back to reference Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Pérez-Gracia JL, Bendandi M, Palencia B, Hervás-Stubbs S, Melero I: Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer. Expert Opin Biol Ther. 2007, 7: 599-615. 10.1517/14712598.7.5.599CrossRefPubMed Arina A, Murillo O, Dubrot J, Azpilikueta A, Alfaro C, Pérez-Gracia JL, Bendandi M, Palencia B, Hervás-Stubbs S, Melero I: Cellular liaisons of natural killer lymphocytes in immunology and immunotherapy of cancer. Expert Opin Biol Ther. 2007, 7: 599-615. 10.1517/14712598.7.5.599CrossRefPubMed
7.
8.
go back to reference Farag SS, Caligiuri MA: Human natural killer cell development and biology. Blood Rev. 2006, 20: 123-137. 10.1016/j.blre.2005.10.001CrossRefPubMed Farag SS, Caligiuri MA: Human natural killer cell development and biology. Blood Rev. 2006, 20: 123-137. 10.1016/j.blre.2005.10.001CrossRefPubMed
9.
go back to reference Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R: Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother. 2011, 60: 1195-1205. 10.1007/s00262-011-1050-2CrossRefPubMed Sanchez-Correa B, Morgado S, Gayoso I, Bergua JM, Casado JG, Arcos MJ, Bengochea ML, Duran E, Solana R, Tarazona R: Human NK cells in acute myeloid leukaemia patients: analysis of NK cell-activating receptors and their ligands. Cancer Immunol Immunother. 2011, 60: 1195-1205. 10.1007/s00262-011-1050-2CrossRefPubMed
10.
go back to reference Seebach JD, Waneck GL: Natural killer cells in xenotransplantation. Xenotransplantation. 1997, 4: 201-211. 10.1111/j.1399-3089.1997.tb00184.x.CrossRef Seebach JD, Waneck GL: Natural killer cells in xenotransplantation. Xenotransplantation. 1997, 4: 201-211. 10.1111/j.1399-3089.1997.tb00184.x.CrossRef
11.
go back to reference Ljunggren HG, Kärre K: In search of the “missing self”: MHC molecules and NK cell recognition. Immunol Today. 1990, 11: 237-244.CrossRefPubMed Ljunggren HG, Kärre K: In search of the “missing self”: MHC molecules and NK cell recognition. Immunol Today. 1990, 11: 237-244.CrossRefPubMed
12.
go back to reference Vivier E, Nunès JA, Vély F: Natural killer cell signaling pathways. Science. 2004, 306: 1517-1519. 10.1126/science.1103478CrossRefPubMed Vivier E, Nunès JA, Vély F: Natural killer cell signaling pathways. Science. 2004, 306: 1517-1519. 10.1126/science.1103478CrossRefPubMed
13.
go back to reference Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science. 2011, 331: 44-49. 10.1126/science.1198687PubMedCentralCrossRefPubMed Vivier E, Raulet DH, Moretta A, Caligiuri MA, Zitvogel L, Lanier LL, Yokoyama WM, Ugolini S: Innate or adaptive immunity? The example of natural killer cells. Science. 2011, 331: 44-49. 10.1126/science.1198687PubMedCentralCrossRefPubMed
14.
go back to reference Cullen SP, Martin SJ: Mechanisms of granule-dependent killing. Cell Death Differ. 2008, 15: 251-262. 10.1038/sj.cdd.4402244CrossRefPubMed Cullen SP, Martin SJ: Mechanisms of granule-dependent killing. Cell Death Differ. 2008, 15: 251-262. 10.1038/sj.cdd.4402244CrossRefPubMed
15.
go back to reference Pardo J, Aguilo JI, Anel A, Martin P, Joeckel L, Borner C, Wallich R, Müllbacher A, Froelich CJ, Simon MM: The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes Infect. 2009, 11: 452-459. 10.1016/j.micinf.2009.02.004CrossRefPubMed Pardo J, Aguilo JI, Anel A, Martin P, Joeckel L, Borner C, Wallich R, Müllbacher A, Froelich CJ, Simon MM: The biology of cytotoxic cell granule exocytosis pathway: granzymes have evolved to induce cell death and inflammation. Microbes Infect. 2009, 11: 452-459. 10.1016/j.micinf.2009.02.004CrossRefPubMed
16.
go back to reference Nüssler NC, Stange BJ, Petzold M, Nussler AK, Glanemann M, Guckelberger O: Reduced NK-cell activity in patients with metastatic colon cancer. EXCLI J. 2007, 6: 1-9. Nüssler NC, Stange BJ, Petzold M, Nussler AK, Glanemann M, Guckelberger O: Reduced NK-cell activity in patients with metastatic colon cancer. EXCLI J. 2007, 6: 1-9.
17.
go back to reference Saijo N, Ozaki A, Beppu Y, Takahashi K, Fujita J, Sasaki Y, Nomori H, Kimata M, Shimizu E, Hoshi A: Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents. J Cancer Res Clin Oncol. 1984, 107: 157-163. 10.1007/BF01032600CrossRefPubMed Saijo N, Ozaki A, Beppu Y, Takahashi K, Fujita J, Sasaki Y, Nomori H, Kimata M, Shimizu E, Hoshi A: Analysis of metastatic spread and growth of tumor cells in mice with depressed natural killer activity by anti-asialo GM1 antibody or anticancer agents. J Cancer Res Clin Oncol. 1984, 107: 157-163. 10.1007/BF01032600CrossRefPubMed
18.
go back to reference Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer. 1982, 30: 107-112. 10.1002/ijc.2910300118CrossRefPubMed Gorelik E, Wiltrout RH, Okumura K, Habu S, Herberman RB: Role of NK cells in the control of metastatic spread and growth of tumor cells in mice. Int J Cancer. 1982, 30: 107-112. 10.1002/ijc.2910300118CrossRefPubMed
19.
go back to reference Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP: Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun. 1991, 5: 193-205. 10.1016/0889-1591(91)90016-4CrossRefPubMed Ben-Eliyahu S, Yirmiya R, Liebeskind JC, Taylor AN, Gale RP: Stress increases metastatic spread of a mammary tumor in rats: evidence for mediation by the immune system. Brain Behav Immun. 1991, 5: 193-205. 10.1016/0889-1591(91)90016-4CrossRefPubMed
20.
go back to reference Liljefors M, Nilsson B, Hjelm Skog A-L, Ragnhammar P, Mellstedt H, Frödin J-E: Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. Int J Cancer. 2003, 105: 717-723. 10.1002/ijc.11139CrossRefPubMed Liljefors M, Nilsson B, Hjelm Skog A-L, Ragnhammar P, Mellstedt H, Frödin J-E: Natural killer (NK) cell function is a strong prognostic factor in colorectal carcinoma patients treated with the monoclonal antibody 17-1A. Int J Cancer. 2003, 105: 717-723. 10.1002/ijc.11139CrossRefPubMed
21.
go back to reference Ménard C, Blay J-Y, Borg C, Michiels S, Ghiringhelli F, Robert C, Nonn C, Chaput N, Taïeb J, Delahaye NF, Flament C, Emile J-F, Le Cesne A, Zitvogel L: Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Cancer Res. 2009, 69: 3563-3569. 10.1158/0008-5472.CAN-08-3807CrossRefPubMed Ménard C, Blay J-Y, Borg C, Michiels S, Ghiringhelli F, Robert C, Nonn C, Chaput N, Taïeb J, Delahaye NF, Flament C, Emile J-F, Le Cesne A, Zitvogel L: Natural killer cell IFN-gamma levels predict long-term survival with imatinib mesylate therapy in gastrointestinal stromal tumor-bearing patients. Cancer Res. 2009, 69: 3563-3569. 10.1158/0008-5472.CAN-08-3807CrossRefPubMed
22.
go back to reference Sodeur S, Ullrich S, Gustke H, Zangemeister-Wittke U, Schumacher U: Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice. Cancer Lett. 2009, 282: 146-151. 10.1016/j.canlet.2009.03.005CrossRefPubMed Sodeur S, Ullrich S, Gustke H, Zangemeister-Wittke U, Schumacher U: Increased numbers of spontaneous SCLC metastasis in absence of NK cells after subcutaneous inoculation of different SCLC cell lines into pfp/rag2 double knock out mice. Cancer Lett. 2009, 282: 146-151. 10.1016/j.canlet.2009.03.005CrossRefPubMed
23.
go back to reference Eccles SA: Basic principles for the study of metastasis using animal models. Metastasis Research Protocols: Volume II. Edited by: Brooks SA, Schumacher U. 2001, 161-171. [Methods in Molecular Medicine™, vol. 58], Totowa, New Jersey: Humana Press,CrossRef Eccles SA: Basic principles for the study of metastasis using animal models. Metastasis Research Protocols: Volume II. Edited by: Brooks SA, Schumacher U. 2001, 161-171. [Methods in Molecular Medicine™, vol. 58], Totowa, New Jersey: Humana Press,CrossRef
24.
25.
go back to reference Gellert M: V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002, 71: 101-132. 10.1146/annurev.biochem.71.090501.150203CrossRefPubMed Gellert M: V(D)J recombination: RAG proteins, repair factors, and regulation. Annu Rev Biochem. 2002, 71: 101-132. 10.1146/annurev.biochem.71.090501.150203CrossRefPubMed
26.
go back to reference Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MT, Young JD, Ahmed R, Clark WR: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A. 1994, 91: 10854-10858. 10.1073/pnas.91.23.10854PubMedCentralCrossRefPubMed Walsh CM, Matloubian M, Liu CC, Ueda R, Kurahara CG, Christensen JL, Huang MT, Young JD, Ahmed R, Clark WR: Immune function in mice lacking the perforin gene. Proc Natl Acad Sci U S A. 1994, 91: 10854-10858. 10.1073/pnas.91.23.10854PubMedCentralCrossRefPubMed
27.
go back to reference Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992, 68: 855-867. 10.1016/0092-8674(92)90029-CCrossRefPubMed Shinkai Y, Rathbun G, Lam KP, Oltz EM, Stewart V, Mendelsohn M, Charron J, Datta M, Young F, Stall AM: RAG-2-deficient mice lack mature lymphocytes owing to inability to initiate V(D)J rearrangement. Cell. 1992, 68: 855-867. 10.1016/0092-8674(92)90029-CCrossRefPubMed
28.
go back to reference Lowin B, Peitsch MC, Tschopp J: Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol. 1995, 198: 1-24.PubMed Lowin B, Peitsch MC, Tschopp J: Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Curr Top Microbiol Immunol. 1995, 198: 1-24.PubMed
29.
go back to reference Magnusson KE, Gustafsson M, Holmgren K, Johansson B: Small intestinal differentiation in human colon carcinoma HT29 cells has distinct effects on the lateral diffusion of lipids (ganglioside GM1) and proteins (HLA class 1, HLA class 2, and neoplastic epithelial antigens) in the apical cell membrane. J Cell Physiol. 1990, 143: 381-390. 10.1002/jcp.1041430224CrossRefPubMed Magnusson KE, Gustafsson M, Holmgren K, Johansson B: Small intestinal differentiation in human colon carcinoma HT29 cells has distinct effects on the lateral diffusion of lipids (ganglioside GM1) and proteins (HLA class 1, HLA class 2, and neoplastic epithelial antigens) in the apical cell membrane. J Cell Physiol. 1990, 143: 381-390. 10.1002/jcp.1041430224CrossRefPubMed
30.
go back to reference Wedemann G, Bethge A, Haustein V, Schumacher U: Computer simulation of the metastatic progression. Metastasis Research Protocols. 2014, 107-116. [Methods in Molecular Biology, vol. 1070], New York: Springer, 2,CrossRef Wedemann G, Bethge A, Haustein V, Schumacher U: Computer simulation of the metastatic progression. Metastasis Research Protocols. 2014, 107-116. [Methods in Molecular Biology, vol. 1070], New York: Springer, 2,CrossRef
31.
go back to reference Bethge A, Schumacher U, Wree A, Wedemann G: Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS One. 2012, 7: e35689- 10.1371/journal.pone.0035689PubMedCentralCrossRefPubMed Bethge A, Schumacher U, Wree A, Wedemann G: Are metastases from metastases clinical relevant? Computer modelling of cancer spread in a case of hepatocellular carcinoma. PLoS One. 2012, 7: e35689- 10.1371/journal.pone.0035689PubMedCentralCrossRefPubMed
33.
go back to reference Smyth MJ, Hayakawa Y, Takeda K, Yagita H: New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002, 2: 850-861. 10.1038/nrc928CrossRefPubMed Smyth MJ, Hayakawa Y, Takeda K, Yagita H: New aspects of natural-killer-cell surveillance and therapy of cancer. Nat Rev Cancer. 2002, 2: 850-861. 10.1038/nrc928CrossRefPubMed
35.
go back to reference Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997, 79: 2320-2328. 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-PCrossRefPubMed Coca S, Perez-Piqueras J, Martinez D, Colmenarejo A, Saez MA, Vallejo C, Martos JA, Moreno M: The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer. 1997, 79: 2320-2328. 10.1002/(SICI)1097-0142(19970615)79:12<2320::AID-CNCR5>3.0.CO;2-PCrossRefPubMed
36.
go back to reference Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, Schirmacher P, Brand K, Grabe N, Falk CS: Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res. 2011, 17: 678-689. 10.1158/1078-0432.CCR-10-2173CrossRefPubMed Halama N, Braun M, Kahlert C, Spille A, Quack C, Rahbari N, Koch M, Weitz J, Kloor M, Zoernig I, Schirmacher P, Brand K, Grabe N, Falk CS: Natural killer cells are scarce in colorectal carcinoma tissue despite high levels of chemokines and cytokines. Clin Cancer Res. 2011, 17: 678-689. 10.1158/1078-0432.CCR-10-2173CrossRefPubMed
37.
go back to reference Nakamura H, Kawasaki N, Hagiwara M, Saito M, Konaka C, Kato H: Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung Cancer. 2000, 28: 139-145. 10.1016/S0169-5002(99)00133-6CrossRefPubMed Nakamura H, Kawasaki N, Hagiwara M, Saito M, Konaka C, Kato H: Cellular immunologic parameters related to age, gender, and stage in lung cancer patients. Lung Cancer. 2000, 28: 139-145. 10.1016/S0169-5002(99)00133-6CrossRefPubMed
38.
go back to reference Kajitani K, Tanaka Y, Arihiro K, Kataoka T, Ohdan H: Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells. Breast Cancer Res Treat. 2012, 134: 139-155. 10.1007/s10549-011-1944-xCrossRefPubMed Kajitani K, Tanaka Y, Arihiro K, Kataoka T, Ohdan H: Mechanistic analysis of the antitumor efficacy of human natural killer cells against breast cancer cells. Breast Cancer Res Treat. 2012, 134: 139-155. 10.1007/s10549-011-1944-xCrossRefPubMed
39.
go back to reference Sjöström-Mattson J, Von Boguslawski K, Bengtsson N-O, Mjaaland I, Salmenkivi K, Blomqvist C: The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncol. 2009, 48: 1137-1143. 10.3109/02841860902988688CrossRefPubMed Sjöström-Mattson J, Von Boguslawski K, Bengtsson N-O, Mjaaland I, Salmenkivi K, Blomqvist C: The expression of p53, bcl-2, bax, fas and fasL in the primary tumour and lymph node metastases of breast cancer. Acta Oncol. 2009, 48: 1137-1143. 10.3109/02841860902988688CrossRefPubMed
40.
go back to reference Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DMS, Banerjee S, Das K, Sa G, Das T: Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Carcinogenesis. 2010, 31: 259-268. 10.1093/carcin/bgp240CrossRefPubMed Lahiry L, Saha B, Chakraborty J, Adhikary A, Mohanty S, Hossain DMS, Banerjee S, Das K, Sa G, Das T: Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Carcinogenesis. 2010, 31: 259-268. 10.1093/carcin/bgp240CrossRefPubMed
41.
go back to reference Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002, 2: 735-747. 10.1038/nri911CrossRefPubMed Trapani JA, Smyth MJ: Functional significance of the perforin/granzyme cell death pathway. Nat Rev Immunol. 2002, 2: 735-747. 10.1038/nri911CrossRefPubMed
42.
go back to reference Mitchell MJ, Wayne E, Rana K, Schaffer CB, King MR: TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A. 2014, 111: 930-935. 10.1073/pnas.1316312111PubMedCentralCrossRefPubMed Mitchell MJ, Wayne E, Rana K, Schaffer CB, King MR: TRAIL-coated leukocytes that kill cancer cells in the circulation. Proc Natl Acad Sci U S A. 2014, 111: 930-935. 10.1073/pnas.1316312111PubMedCentralCrossRefPubMed
43.
go back to reference Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA, Navaratnam V, Ryder S: Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010, 102: 1555-1577. 10.1038/sj.bjc.6605642PubMedCentralCrossRefPubMed Workman P, Aboagye EO, Balkwill F, Balmain A, Bruder G, Chaplin DJ, Double JA, Everitt J, Farningham DAH, Glennie MJ, Kelland LR, Robinson V, Stratford IJ, Tozer GM, Watson S, Wedge SR, Eccles SA, Navaratnam V, Ryder S: Guidelines for the welfare and use of animals in cancer research. Br J Cancer. 2010, 102: 1555-1577. 10.1038/sj.bjc.6605642PubMedCentralCrossRefPubMed
44.
go back to reference Jojovic M, Schumacher U: Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett. 2000, 152: 151-156. 10.1016/S0304-3835(99)00443-7CrossRefPubMed Jojovic M, Schumacher U: Quantitative assessment of spontaneous lung metastases of human HT29 colon cancer cells transplanted into SCID mice. Cancer Lett. 2000, 152: 151-156. 10.1016/S0304-3835(99)00443-7CrossRefPubMed
45.
go back to reference Nehmann N, Wicklein D, Schumacher U, Müller R: Comparison of two techniques for the screening of human tumor cells in mouse blood: quantitative real-time polymerase chain reaction (qRT-PCR) versus laser scanning cytometry (LSC). Acta Histochem. 2010, 112: 489-496. 10.1016/j.acthis.2009.05.004CrossRefPubMed Nehmann N, Wicklein D, Schumacher U, Müller R: Comparison of two techniques for the screening of human tumor cells in mouse blood: quantitative real-time polymerase chain reaction (qRT-PCR) versus laser scanning cytometry (LSC). Acta Histochem. 2010, 112: 489-496. 10.1016/j.acthis.2009.05.004CrossRefPubMed
46.
go back to reference Mulisch M, Welsch U: Romeis Mikroskopische Technik. 2010, Heidelberg: Spektrum Akademischer Verlag GmbH, Mulisch M, Welsch U: Romeis Mikroskopische Technik. 2010, Heidelberg: Spektrum Akademischer Verlag GmbH,
47.
go back to reference Iwata K, Kawasaki K, Shigesada N: A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol. 2000, 203: 177-186. 10.1006/jtbi.2000.1075CrossRefPubMed Iwata K, Kawasaki K, Shigesada N: A dynamical model for the growth and size distribution of multiple metastatic tumors. J Theor Biol. 2000, 203: 177-186. 10.1006/jtbi.2000.1075CrossRefPubMed
49.
go back to reference Chiarella P, Bruzzo J, Meiss RP, Ruggiero RA: Concomitant tumor resistance. Cancer Lett. 2012, 324: 133-141. 10.1016/j.canlet.2012.05.021CrossRefPubMed Chiarella P, Bruzzo J, Meiss RP, Ruggiero RA: Concomitant tumor resistance. Cancer Lett. 2012, 324: 133-141. 10.1016/j.canlet.2012.05.021CrossRefPubMed
50.
go back to reference Wikman H, Vessella R, Pan℡ K: Cancer micrometastasis and tumour dormancy. APMIS. 2008, 116: 754-770. 10.1111/j.1600-0463.2008.01033.xCrossRefPubMed Wikman H, Vessella R, Pan℡ K: Cancer micrometastasis and tumour dormancy. APMIS. 2008, 116: 754-770. 10.1111/j.1600-0463.2008.01033.xCrossRefPubMed
Metadata
Title
Perforin-dependent direct cytotoxicity in natural killer cells induces considerable knockdown of spontaneous lung metastases and computer modelling-proven tumor cell dormancy in a HT29 human colon cancer xenograft mouse model
Authors
Tobias Brodbeck
Nina Nehmann
Anja Bethge
Gero Wedemann
Udo Schumacher
Publication date
01-12-2014
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2014
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-13-244

Other articles of this Issue 1/2014

Molecular Cancer 1/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine